Its tumor-specific coincidence with the LAMP3+ DC suggests that mesenchymal-derived interferon is necessary to initiate the tumor interferon signaling for the subsequent recruitment of immune cells and T cell priming. The gene discussed is LAMP3; the disease is neoplasm.